1.	Introduction

1.1	 History 

Johnson & Johnson is a multinational corporation founded in 1886 by three brothers: Robert Wood Johnson, James Wood Johnson as well as Edward Mead Johnson. It headquarter is in New Brunswick, New Jersey, NJ, USA. The company operates in the healthcare industry, encompassing three main sectors: medicines, medical devices, and cosmetics, respectively.
1.2	 Business Model

The main focus of Johnson & Johnson¢ business approach is to research and develop new products. The company dedicates itself to the production of the well-built health-related products that meet a plethora of demands globally. It facilitates great innovations and discoveries through investing heavily on the research and development to bring forth new and advanced drug products to the market addressing different health issues including simple wellness and complicated ailments.
1.3	 Market Place

Johnson & Johnson is a worldwide health care industry company, and is from 60 countries is located and 175 countries sold products. The organization's diversified portfolio is a means of way to satisfy all the needs of the market that include pharmaceutical, medical equipment, over-the-counter products, etc. It renders a wide range of distribution in the developed as well as outreach markets, and its primary function remains responding to and providing healthcare around the world.
1.4	 Major Competitors

•	Pfizer Inc. is a diverse global pharmaceutical corporation that competes against the Johnson & Johnson Corporation to increase the market share in the pharmaceuticals segment.
•	Novartis AG - A (multidisciplinary) pharmaceutical cooperative company from Switzerland that competes in various pharmaceutical fields.
•	Merck & Co., Inc. – an American multinational pharmaceutical corporation that concurrently represents a rival to Johnson & Johnson in the development and marketing of medications.
•	Abbott Laboratories - It is a healthcare firm that fights against Johnson & Johnson in two arena of medical devices and diagnostics.
•	Procter & Gamble - The company spanning several nations that is just as strong in market as Johnson & Johnson in the consumer health products market.
J&J has borrowed the opportunity to show the market its innovation, wide range of products and broad global presence making it a key player in the ever growing healthcare industry, and its competitors, however, keep on strengthening too.
1.5	  Major Event of J&J

2019:
Legal Issues: Johnson & Johnson got into many legal troubles for its products, among them was the lawsuit case about the usage of talcum powder that could have led to cancer. At the end of October 2019, the company recalled a whole batch of one of their bestselling products that was sold all around the country, after the FDA discovered a tiny particles of asbestos in one of the bottles by chance.
2020:
COVID-19 Vaccine Development: Johnson & Johnson mentioned the development of a vaccine for COVID-19 and got the ‘emergency use authorization’ status from the FDA in February 2021. The company's single-dose vaccine that was added to the existing global vaccine supplies line was an important expansion of the global vaccine supply.
2021:
Strategic Change: Johnson & Johnson, on its part, disclosed its intention to tear off its consumer health division and list it as a publicly traded company. By this means the organization had a possibility to occupy itself with its main area of professional pharmaceutical and medical devices.
2022:
Legal Settlement: On the 18th of February, 2022, Johnson & Johnson and its subsidiary, DePuy Synthes, settled claims of subscribing to the False Claims Act for promoting the medical devices for no approved reasons.
2023:
Acquisition: In February 2023, a subdivision of Johnson & Johnson - Janssen Pharmaceutical Companies Inc. announced the acquisition of Hemab Therapeutics, a company that is engaged in developing drugs for serious blood disorders. This respective acquisition is emphasized to strengthen J &J hematology portfolio.